Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

Tze‐Fan Chao; Yi‐Hsin Chan; Chern‐En Chiang; Ta‐Chuan Tuan; Jo‐Nan Liao; Tzeng‐Ji Chen; Professor Gregory Lip; Shih‐Ann Chen

doi:10.1093/ehjqcco/qcab076

Back

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

Article 2021 en

Abstract

1 min read

In routine clinical care, DOACs (whether reduced or full dose) were associated with a lower risk of ischaemic stroke, mortality, and the composite endpoint, when compared with non-OAC use in high-risk elderly AF patients at increased bleeding risk. Our findings provide complementary 'real-world' data to support the generalizability of the results of the ELDERCARE-AF trial to other DOACs in daily clinical practice.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Article2021

Clinical Characteristics and Outcomes of Very Elderly Patients With Atrial Fibrillation at High Bleeding Risk　― The Fushimi AF Registry ―

Yuya Ide, Hisashi Ogawa, Kenjiro Ishigami, Syuhei Ikeda, Kosuke Doi, Yasuhiro Hamatani, Akiko Fujino, Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Professor Gregory Lip, Masaharu Akao

Article2025

Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study.

Y. Go, So-Ryoung Lee, Hyo‐Jeong Ahn, Kyungdo Han, Seil Oh, Professor Gregory Lip

Article2020

Oral anticoagulants in extremely high risk very elderly (&gt;90 years) patients with Atrial Fibrillation

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Article2023

Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia

Tze‐Fan Chao, Ling Kuo, Professor Gregory Lip, S A Chen

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

Abstract

Discussion(0)

Related publications

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Clinical Characteristics and Outcomes of Very Elderly Patients With Atrial Fibrillation at High Bleeding Risk ― The Fushimi AF Registry ―

Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study.

Oral anticoagulants in extremely high risk very elderly (&amp;gt;90 years) patients with Atrial Fibrillation

Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia

Clinical Characteristics and Outcomes of Very Elderly Patients With Atrial Fibrillation at High Bleeding Risk　― The Fushimi AF Registry ―

Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation